Uruguay launches free meningococcal vaccination drive amid disease surge

Uruguay is facing a critical public health situation due to an unusual rise in meningococcal disease cases, prompting urgent vaccination efforts. The Ministry of Public Health (MSP) has confirmed 20 cases of the illness, resulting in five fatalities, with 70% of infections attributed to the serotype C.

“

The 70% of cases belong to serotype C, so it has launched progressive preventive measures aimed at protecting public health and containing the disease.

In response, the Intendencia de Montevideo (IMM) has launched a free vaccination campaign targeting children born on or after January 1, 2014. This initiative aims to immunize individuals aged 11 and 12, striving for over 90% coverage to achieve herd immunity. Intensive vaccination days are scheduled, with extended hours at health centers to ensure accessibility.

Health authorities are also reinforcing the importance of standard preventive measures, including frequent hand washing, adequate ventilation of indoor spaces, and covering coughs and sneezes. These actions are crucial as the meningococcus bacteria spreads through close respiratory contact.

“

The goal is to achieve over 90% coverage, which will allow for the 'herd effect'.

Meningococcal disease, caused by the bacterium Neisseria meningitidis, can lead to meningitis or bloodstream infections. The MSP emphasizes the need for rapid symptom recognition, such as high fever, severe headache, neck stiffness, and skin rash, as the illness can progress rapidly and have severe consequences, including permanent disabilities or death. The MSP continues to monitor the situation and will provide updates.

“

The rapid evolution of the disease makes early recognition of symptoms such as high fever, intense headache, neck stiffness, red spots on the skin that do not disappear when pressed, persistent nausea and vomiting, and discomfort with light vital for treatment.